{
  "ticker": "LLY",
  "target_date": "2025-09-03",
  "actual_date": "2025-09-03",
  "collected_at": "2025-12-08T12:14:00.438982",
  "price": {
    "open": 730.95,
    "high": 736.75,
    "low": 727.95,
    "close": 736.748046875,
    "volume": 2222500,
    "change_1d_pct": 0.36,
    "change_7d_pct": 3.67,
    "change_30d_pct": -4.76
  },
  "technicals": {
    "rsi_14": 81.27,
    "sma_20": 696.72,
    "sma_50": 744.89,
    "macd": -1.398,
    "macd_signal": -9.293,
    "macd_histogram": 7.895,
    "bb_upper": 774.75,
    "bb_lower": 618.69,
    "price_vs_sma20_pct": 5.75,
    "price_vs_sma50_pct": -1.09,
    "volume_ratio": 0.33
  },
  "fundamentals": {
    "market_cap": 892279324672,
    "pe_ratio": 48.767273,
    "forward_pe": 43.92498,
    "price_to_book": 37.47515,
    "price_to_sales": 15.016532,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.49,
    "pct_from_52w_low": 59.57
  },
  "macro": {
    "spy": {
      "price": 641.96,
      "change_1d_pct": 0.54,
      "change_7d_pct": 0.2
    },
    "vix": {
      "level": 16.35,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.21
    },
    "dollar_index": {
      "level": 98.14
    },
    "gold": {
      "price": 3593.2
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly Wins Fresh Bullish Call From BMO",
      "source": "Yahoo",
      "datetime": 1756939920,
      "summary": "$840 target backed by optimism on new obesity drug",
      "url": "https://finnhub.io/api/news?id=52cbee5b220b94fbddd2f96445d7a670ffe429d282e0142e4dd397afe55530ad"
    },
    {
      "headline": "Factbox-Global drugmakers rush to boost US presence as tariff threat looms",
      "source": "Yahoo",
      "datetime": 1756926558,
      "summary": "But with many countries still engaged in trade talks with the U.S., businesses around the world are hedging their decisions pending more clarity on final tariff rates.  The U.S. drugmaker plans to invest $27 billion to build four new manufacturing facilities over the next five years in the U.S. It a",
      "url": "https://finnhub.io/api/news?id=35abbd617332d141878bb80b64dd0dff91b88df1fc45fda598bd74021d9a119e"
    },
    {
      "headline": "The Problem With Weight Loss Stocks",
      "source": "Yahoo",
      "datetime": 1756925280,
      "summary": "There are new ways to tackle weight loss, but the stocks leading the way are lagging.",
      "url": "https://finnhub.io/api/news?id=ccbc1daa7b31533fea3632007c13c51ba380e0b85ab1192159d67a0c6b07af4e"
    },
    {
      "headline": "Hims & Hers gains after court rejects Eli Lilly\u2019s case against Willow",
      "source": "Yahoo",
      "datetime": 1756923592,
      "summary": "Investing.com -- Shares of Hims Hers Health Inc (NYSE:HIMS) jumped 8.2% Wednesday after a key legal development eased market concerns about potential litigation from major pharmaceutical companies. A federal judge\u2019s dismissal of Eli Lilly\u2019s (NYSE:LLY) lawsuit against Willow Health, a telehealth prov",
      "url": "https://finnhub.io/api/news?id=f32345b987875b719ebd72e1f4e25c848ef1f262421d16e368e3a4d42c9e5dd6"
    },
    {
      "headline": "Jim Cramer Urges Patience With Eli Lilly and Company (LLY)\u2019s Stock",
      "source": "Yahoo",
      "datetime": 1756919539,
      "summary": "We recently published 9 Stocks On Jim Cramer\u2019s Radar . Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Weight loss drug giant Eli Lilly and Company (NYSE:LLY)\u2019s shares have lost 5.9% year-to-date as investors have questioned the firm\u2019s weight loss drug trials. Cr",
      "url": "https://finnhub.io/api/news?id=54753dea1e74f79cb526770f02364ab66664316347d25b9f48f126e31ea4b5b1"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412129.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000236/xslF345X05/wk-form4_1756412129.xml"
    },
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412046.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000234/xslF345X05/wk-form4_1756412046.xml"
    },
    {
      "form": "8-K",
      "date": "2025-08-20",
      "description": "d929636d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312525184093/d929636d8k.htm"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634987.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000232/xslF345X05/wk-form4_1755634987.xml"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634943.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000230/xslF345X05/wk-form4_1755634943.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}